Closure of Trading Window
Filed with BSE · · 1 page · English
Summary by 6ix AI
Venmax Drugs & Pharmaceuticals Ltd. has announced the closure of its trading window for insiders, effective from a specified date after the upcoming financial results announcement. This closure is in compliance with insider trading regulations and the company's own code of conduct. The exact date for the board meeting to discuss the financial results will be communicated later.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 08 2026
- Announcement under Regulation 30 (LODR)-Scheme of Arrangement
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 01 2026
- Reg. 34 (1) Annual Report.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 31 2026
Later from Venmax Drugs & Pharmaceuticals
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 26 2026
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 28 2026
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals